Patents by Inventor Timothy Varney

Timothy Varney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MESENCHYMAL STEM CELLS AND USES THEREFOR
    Publication number: 20230076630
    Abstract: Compositions and methods of promoting wound healing in a human by administering to the human mesenchymal stem cells in an effective amount.
    Type: Application
    Filed: June 9, 2022
    Publication date: March 9, 2023
    Inventors: Sudeepta Aggarwal, Mark F. Pittenger, Timothy Varney
  • Mesenchymal stem cells and uses therefor
    Patent number: 11389484
    Abstract: Compositions and methods of promoting wound healing in a human by administering to the human mesenchymal stem cells in an effective amount.
    Type: Grant
    Filed: December 10, 2018
    Date of Patent: July 19, 2022
    Assignee: Mesoblast International Sárl
    Inventors: Sudeepta Aggarwal, Mark F. Pittenger, Timothy Varney
  • Mesenchymal stem cells and uses therefor
    Patent number: 10960025
    Abstract: Compositions and methods of promoting wound healing in a human by administering to the human mesenchymal stem cells in an effective amount.
    Type: Grant
    Filed: March 6, 2020
    Date of Patent: March 30, 2021
    Assignee: Mesoblast International Sárl
    Inventors: Sudeepta Aggarwal, Mark F. Pittenger, Timothy Varney
  • MESENCHYMAL STEM CELLS AND USES THEREFOR
    Publication number: 20200360442
    Abstract: Compositions and methods of promoting wound healing in a human by administering to the human mesenchymal stem cells in an effective amount.
    Type: Application
    Filed: March 11, 2020
    Publication date: November 19, 2020
    Inventors: Sudeepta AGGARWAL, Mark F. PITTENGER, Timothy VARNEY
  • Mesenchymal stem cells and uses therefor
    Patent number: 10828334
    Abstract: Compositions and methods of promoting wound healing in a human by administering to the human mesenchymal stem cells in an effective amount.
    Type: Grant
    Filed: March 11, 2020
    Date of Patent: November 10, 2020
    Assignee: Mesoblast International Sárl
    Inventors: Sudeepta Aggarwal, Mark F. Pittenger, Timothy Varney
  • MESENCHYMAL STEM CELLS AND USES THEREFOR
    Publication number: 20200246387
    Abstract: Compositions and methods of promoting wound healing in a human by administering to the human mesenchymal stem cells in an effective amount.
    Type: Application
    Filed: March 6, 2020
    Publication date: August 6, 2020
    Inventors: Sudeepta AGGARWAL, Mark F. PITTENGER, Timothy VARNEY
  • Mesenchymal stem cells and uses therefor
    Patent number: 10729727
    Abstract: Compositions and methods of promoting wound healing in a human by administering to the human mesenchymal stem cells in an effective amount.
    Type: Grant
    Filed: November 29, 2018
    Date of Patent: August 4, 2020
    Assignee: Mesoblast International Sárl
    Inventors: Sudeepta Aggarwal, Mark F. Pittenger, Timothy Varney
  • Mesenchymal stem cells and uses therefor
    Patent number: 10716814
    Abstract: Compositions and methods of promoting wound healing in a human by administering to the human mesenchymal stem cells in an effective amount.
    Type: Grant
    Filed: November 30, 2018
    Date of Patent: July 21, 2020
    Assignee: Mesoblast International Sàrl
    Inventors: Sudeepta Aggarwal, Mark F. Pittenger, Timothy Varney
  • Mesenchymal stem cells and uses therefor
    Patent number: 10668101
    Abstract: Compositions and methods of promoting wound healing in a human by administering to the human mesenchymal stem cells in an effective amount.
    Type: Grant
    Filed: December 23, 2013
    Date of Patent: June 2, 2020
    Assignee: MESOBLAST INTERNATIONAL SÁRL
    Inventors: Sudeepta Aggarwal, Mark F. Pittenger, Timothy Varney
  • Device and method for isolation of corneal endothelial cells
    Patent number: 10493455
    Abstract: An apparatus for isolating corneal endothelial cells (CECs) includes a housing with an interior wall that defines a hollow interior of the housing. At least four fluid channels are formed in the housing with two of the channels terminating in respective openings in an upper portion of the interior wall and two of the channels terminating in respective jets in the upper portion of the interior wall. A convex projection is centrally located on the circular base of the hollow interior and is configured to receive an inverted cornea. A circular insert for the housing has an opening therein in which the convex projection projects when the insert is mated with the lower portion of the interior wall. CECs are harvested from the inverted cornea.
    Type: Grant
    Filed: October 26, 2018
    Date of Patent: December 3, 2019
    Assignee: The Government of the United States, as represented by the Secretary of the Army
    Inventors: Robert Haggins, Jr., Erik Eaton, Jr., Zachary Murray, Timothy Varney
  • Device and method for isolation of corneal endothelial cells
    Patent number: 10443032
    Abstract: An apparatus (8) for isolating corneal endothelial cells (34) (CECs) includes a base portion (10) having an interior recessed opening (14) with a bottom surface (16). A convex projection (18) is centrally located on the bottom surface (16) and is configured to receive an inverted cornea (32). A top portion (12) is configured to mate with the base portion (10). The top portion (12) includes a fluid chamber (24) with a lower surface (20). The lower surface (20) has an opening (22) therein in which the convex projection (18) projects when the top portion (12) is mated with the base portion (10).
    Type: Grant
    Filed: April 19, 2017
    Date of Patent: October 15, 2019
    Assignee: The Government of the United States, as represented by the Secretary of the Army
    Inventors: Robert Haggins, Jr., Erik Eaton, Jr., Zachary Murray, Timothy Varney
  • Mesenchymal stem cells and uses therefor
    Patent number: 10391127
    Abstract: Compositions and methods of promoting wound healing in a human by administering to the human mesenchymal stem cells in an effective amount.
    Type: Grant
    Filed: December 23, 2013
    Date of Patent: August 27, 2019
    Assignee: Mesoblast International Sárl
    Inventors: Sudeepta Aggarwal, Mark F. Pittenger, Timothy Varney
  • MESENCHYMAL STEM CELLS AND USES THEREFOR
    Publication number: 20190240259
    Abstract: Compositions and methods of promoting wound healing in a human by administering to the human mesenchymal stem cells in an effective amount.
    Type: Application
    Filed: December 10, 2018
    Publication date: August 8, 2019
    Inventors: Sudeepta AGGARWAL, Mark F. Pittenger, Timothy Varney
  • MESENCHYMAL STEM CELLS AND USES THEREFOR
    Publication number: 20190201447
    Abstract: Compositions and methods of promoting wound healing in a human by administering to the human mesenchymal stem cells: in an effective amount
    Type: Application
    Filed: November 30, 2018
    Publication date: July 4, 2019
    Inventors: Sudeepta AGGARWAL, Mark F. Pittenger, Timothy Varney
  • MESENCHYMAL STEM CELLS AND USES THEREFOR
    Publication number: 20190175657
    Abstract: Compositions and methods of promoting wound healing in a human by administering to the human mesenchymal stem cells in an effective amount.
    Type: Application
    Filed: November 29, 2018
    Publication date: June 13, 2019
    Inventors: Sudeepta AGGARWAL, Mark F. Pittenger, Timothy Varney
  • Device and Method for Isolation of Corneal Endothelial Cells
    Publication number: 20190060903
    Abstract: An apparatus for isolating corneal endothelial cells (CECs) includes a housing with an interior wall that defines a hollow interior of the housing. At least four fluid channels are formed in the housing with two of the channels terminating in respective openings in an upper portion of the interior wall and two of the channels terminating in respective jets in the upper portion of the interior wall. A convex projection is centrally located on the circular base of the hollow interior and is configured to receive an inverted cornea. A circular insert for the housing has an opening therein in which the convex projection projects when the insert is mated with the lower portion of the interior wall. CECs are harvested from the inverted cornea.
    Type: Application
    Filed: October 26, 2018
    Publication date: February 28, 2019
    Applicant: THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY
    Inventors: Robert HAGGINS, Jr., Erik EATON, Jr., Zachary MURRAY, Timothy VARNEY
  • Device and Method for Isolation of Corneal Endothelial Cells
    Publication number: 20190002818
    Abstract: An apparatus (8) for isolating corneal endothelial cells (34) (CECs) includes a base portion (10) having an interior recessed opening (14) with a bottom surface (16). A convex projection (18) is centrally located on the bottom surface (16) and is configured to receive an inverted cornea (32). A top portion (12) is configured to mate with the base portion (10). The top portion (12) includes a fluid chamber (24) with a lower surface (20). The lower surface (20) has an opening (22) therein in which the convex projection (18) projects when the top portion (12) is mated with the base portion (10).
    Type: Application
    Filed: April 19, 2017
    Publication date: January 3, 2019
    Applicant: THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY
    Inventors: Robert HAGGINS, Jr., Erik EATON, Jr., Zachary MURRAY, Timothy VARNEY
  • Mesenchymal stem cells and uses therefor
    Patent number: 9943547
    Abstract: Methods of treating autoimmune diseases, allergic responses, cancer, or inflammatory diseases in an animal, promoting would healing, repairing epithelial damage and promoting angiogenesis in an organ or tissue of an animal by administering to the animal mesenchymal stem cells in an effective amount.
    Type: Grant
    Filed: November 22, 2013
    Date of Patent: April 17, 2018
    Assignee: MESOBLAST INTERNATIONAL SÀRL
    Inventors: Sudeepta Aggarwal, Mark F. Pittenger, Timothy Varney
  • Mesenchymal stem cells and uses therefor
    Patent number: 9694035
    Abstract: Methods of treating autoimmune diseases, allergic responses, cancer, or inflammatory diseases in an animal, promoting wound healing, repairing epithelial damage and promoting angiogenesis in an organ or tissue of an animal by administering to the animal mesenchymal stem cells in an effective amount.
    Type: Grant
    Filed: July 17, 2014
    Date of Patent: July 4, 2017
    Assignee: MESOBLAST INTERNATIONAL SARL
    Inventors: Sudeepta Aggarwal, Mark F. Pittenger, Timothy Varney
  • Mesenchymal Stem Cells and Uses Therefor
    Publication number: 20150272997
    Abstract: Methods of treating autoimmune diseases, allergic responses, cancer, or inflammatory diseases in an animal, promoting wound healing, repairing epithelial damage and promoting angiogenesis in an organ or tissue of an animal by administering to the animal mesenchymal stem cells in an effective amount.
    Type: Application
    Filed: June 15, 2015
    Publication date: October 1, 2015
    Inventors: Sudeepta Aggarwal, Mark F. Pittenger, Timothy Varney